Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Raw Materials (2016 - 2021)

AtriCure (ATRC) has disclosed Raw Materials for 11 consecutive years, with $12.4 million as the latest value for Q2 2021.

  • On a quarterly basis, Raw Materials fell 3.05% to $12.4 million in Q2 2021 year-over-year; TTM through Jun 2021 was $12.4 million, a 3.05% decrease, with the full-year FY2020 number at $12.0 million, up 7.55% from a year prior.
  • Raw Materials was $12.4 million for Q2 2021 at AtriCure, up from $11.3 million in the prior quarter.
  • In the past five years, Raw Materials ranged from a high of $12.8 million in Q2 2020 to a low of $5.8 million in Q2 2017.
  • A 5-year average of $9.7 million and a median of $10.0 million in 2019 define the central range for Raw Materials.
  • Peak YoY movement for Raw Materials: decreased 4.93% in 2017, then skyrocketed 50.19% in 2018.
  • AtriCure's Raw Materials stood at $7.8 million in 2017, then rose by 17.34% to $9.1 million in 2018, then increased by 22.26% to $11.1 million in 2019, then grew by 7.55% to $12.0 million in 2020, then rose by 3.47% to $12.4 million in 2021.
  • Per Business Quant, the three most recent readings for ATRC's Raw Materials are $12.4 million (Q2 2021), $11.3 million (Q1 2021), and $12.0 million (Q4 2020).